Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Accenture
Teva
Covington
Deloitte
Cipla
Farmers Insurance
Chinese Patent Office
Healthtrust

Generated: February 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Avelumab

« Back to Dashboard

US Patents for Avelumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Avelumab ➤ Try a Free Trial Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) ➤ Try a Free Trial
Avelumab ➤ Try a Free Trial Methods of using OX40 ligand encoding polynucleotides ModernaTX, Inc. (Cambridge, MA) ➤ Try a Free Trial
Avelumab ➤ Try a Free Trial Combinations of mRNAs encoding immune modulating polypeptides and uses thereof ModernaTX, Inc. (Cambridge, MA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Avelumab

Drugname Country Document Number Estimated Expiration Related US Patent
Avelumab European Patent Office 3313818 2035-06-26 ➤ Try a Free Trial
Avelumab World Intellectual Property Organization (WIPO) 2016210262 2035-06-26 ➤ Try a Free Trial
Avelumab European Patent Office 3394093 2035-12-23 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Teva
Julphar
QuintilesIMS
Accenture
Queensland Health
Covington
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.